Therapeutic Areas

IBSA UK expands solutions in male sexual health

 

Erectile dysfunction is a very common condition, but one that is often still under-reported. In Western European countries, it is estimated to affect 5-10% of the male population. With advancing age, this percentage gradually increases to reach an average of 40% in men aged 80.

However, it is not a condition linked only to ageing. In recent years, an increase has also been observed among young people, proving that a healthy lifestyle and regular physical activity can also have a significant impact on preventing this condition.

The causes of erectile dysfunction are numerous and often combined. Organic causes mainly include vascular, neurological and hormonal factors, with atherosclerosis, diabetes mellitus and hypogonadism among the main pathogenic mechanisms. Alongside these, psychological factors play a significant role, interacting with biological components in influencing the condition. Performance anxiety, stress, emotional distress or relationship difficulties can contribute to the onset and persistence of the disorder. Recent studies show that anxiety and depression can lead or contribute to erectile dysfunction, creating a vicious circle that further compromises the quality of life.

Therapeutic solutions with simple and intuitive methods of administration are particularly valued, as they promote compliance and simplify the treatment process.

A NEW OPTION AVAILABLE IN BRITISH PHARMACIES

This is the context in which IBSA UK and Boots, the UK’s largest health, beauty and wellness retailer, have developed their partnership, leading to the launch of a treatment for erectile dysfunction, now available without a prescription in selected Boots pharmacies across England. The collaboration with Boots represents a strategic step for IBSA UK, consolidating its role in the UK market. At the same time, it confirms IBSA's global presence in the uro-gynaecological therapeutic area.

The focus on male sexual health is part of a broader vision of well-being, as stated by Steven Knapp, General Manager of IBSA UK: “Our collaboration with Boots enhances patient access to an innovative treatment for erectile dysfunction, providing an important alternative for those for whom conventional tablets may not be suitable. This partnership exemplifies our commitment to advancing patient care through sensitivity, clinical excellence and forward-thinking solutions.

IBSA’S GLOBAL COMMITMENT GROWS

The partnership with Boots confirms IBSA's commitment to a constant growth in its various therapeutic areas, offering innovative and practical solutions designed to respond to people's real needs.

This commitment starts with the research and development of innovative technologies and finds its most authentic meaning in the ability to listen both to the healthcare professionals who work with patients on a daily basis and to people who want to improve their quality of life and well-being in every aspect of their daily routine.